Convergence: where pharmaceuticals have been, devices will follow
This article was originally published in Clinica
Executive Summary
Regulators are increasingly looking at devices and medicines in a similar way when it comes to public perception of quality, safety and efficacy, says consultant Mark Charny*. Current requirements for pharmaceuticals may predict the future of device regulation and reimbursement device companies need to adapt their strategies for early-stage products to manage this change